COAPT Score (MitraClip Responder Model) Calculator
Clinical and echocardiographic inputs
Enter the patient's findings to calculate the point-based COAPT Risk Score.
About the COAPT Risk Score
The COAPT Risk Score is a point-based prognostic model derived from the COAPT trial database. It was developed to estimate the 2-year risk of the composite of all-cause death or heart failure hospitalization among patients with heart failure and significant secondary mitral regurgitation.
The model combines clinical variables, echocardiographic findings, and the M-TEER treatment term. Its use should remain within the context of the population and endpoint for which it was developed.
Score components
| Variable | Model criterion | Points |
|---|---|---|
| COPD | Present | +1 |
| Atrial fibrillation/flutter | Present | +1 |
| NYHA class | III or IVa | +1 |
| eGFR | 30–60 / <30 or ESRD | +1 / +3 |
| LVEF | 25–35% / <25% | +1 / +2 |
| LVESD | >5.5 cm | +2 |
| RVSP | >45 mmHg | +3 |
| TR grade | ≥2+ | +2 |
| M-TEER treatment term | Selected | −3 |
Clinical interpretation
This calculator displays the sum of the published point weights represented in this implementation. It does not calculate an absolute probability or replace the original model's full statistical specification.
- Use alongside clinical assessment, echocardiographic evaluation, GDMT optimization, anatomy, comorbidities, and shared decision-making.
- Do not use the score alone to determine eligibility for M-TEER or to withhold treatment.
- External validation reported variable discrimination across patient subgroups; applicability outside COAPT-like populations requires caution.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.